on The Vanguard Group, Inc. (isin : US12572Q1058)
The Vanguard Group's Position in Mural Oncology plc
The Vanguard Group, Inc. has disclosed its positions in Mural Oncology plc according to the Irish Takeover Panel Act, 1997. As of May 15, 2025, Vanguard holds 772,957 ordinary shares, representing 4.48% of Mural Oncology's relevant securities. The company has not engaged in any derivatives related to these shares, nor are there any short positions listed.
On May 16, 2025, Vanguard reported a small purchase of 126 shares at a unit price of 2.53 USD. The disclosure confirms no other dealings such as derivatives or special agreements influencing this position. Notably, there are no indemnity or option arrangements linked to these securities, and no additional agreements concerning voting rights or future transactions are reported.
R. H.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all The Vanguard Group, Inc. news